We are live on ! Find out more
GT

Glenmede Trust Portfolio holdings

AUM $20.4B
This Fund
S&P 500
This Quarter Est. Return
+9.08%
1 Year Est. Return
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$19.9B
AUM Growth
+$675M
Cap. Flow
-$801M
Cap. Flow %
-4.02%
Top 10 Hldgs %
22.74%
Holding
1,397
New
101
Increased
520
Reduced
573
Closed
56

Top Sells

Rank Stock Value
1
KLAC icon
KLA
KLAC
+$78.4M
2
CDNS icon
Cadence Design Systems
CDNS
+$67.2M
3
BBY icon
Best Buy
BBY
+$49.5M
4
HUM icon
Humana
HUM
+$40.2M
5
LEN icon
Lennar Class A
LEN
+$38.4M

Sector Composition

Rank Sector Weight
1 Technology 22.05%
2 Healthcare 11.68%
3 Financials 10.25%
4 Consumer Discretionary 9.33%
5 Industrials 7.43%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
GAP
1026
The Gap Inc
GAP
$7.3B
$336K ﹤0.01%
12,178
-1,063
-8% -$22.4K
AOS icon
1027
A.O. Smith
AOS
$8.55B
$335K ﹤0.01%
3,741
+599
+19% +$49.4K
ETRN
1028
DELISTED
Equitrans Midstream Corporation Common Stock
ETRN
$333K ﹤0.01%
26,671
PTGX icon
1029
Protagonist Therapeutics
PTGX
$8.55B
$331K ﹤0.01%
+11,451
New +$312K
INGN icon
1030
Inogen
INGN
$174M
$331K ﹤0.01%
41,010
FSLR icon
1031
First Solar
FSLR
$21.4B
$330K ﹤0.01%
1,956
-95
-5% -$14.6K
LSTR icon
1032
Landstar System
LSTR
$6.04B
$330K ﹤0.01%
1,711
HII icon
1033
Huntington Ingalls Industries
HII
$11B
$326K ﹤0.01%
1,119
-10
-0.9% -$2.75K
NCLH icon
1034
Norwegian Cruise Line
NCLH
$9.53B
$326K ﹤0.01%
15,565
-347
-2% -$6.31K
CRNX icon
1035
Crinetics Pharmaceuticals
CRNX
$8.88B
$325K ﹤0.01%
+6,938
New +$271K
HEFA icon
1036
iShares Currency Hedged MSCI EAFE ETF
HEFA
$7.45B
$324K ﹤0.01%
9,293
-175
-2% -$5.76K
FOXF icon
1037
Fox Factory Holding Corp
FOXF
$794M
$322K ﹤0.01%
6,186
+682
+12% +$40.2K
NXP icon
1038
Nuveen Select Tax-Free Income Portfolio
NXP
$898M
$320K ﹤0.01%
22,195
ALC icon
1039
Alcon
ALC
$34B
$320K ﹤0.01%
3,847
+19
+0.5% +$1.52K
AFG icon
1040
American Financial Group
AFG
$11.9B
$319K ﹤0.01%
2,338
POWI icon
1041
Power Integrations
POWI
$3.15B
$319K ﹤0.01%
4,458
-437
-9% -$32.6K
VBTX
1042
DELISTED
Veritex Holdings
VBTX
$319K ﹤0.01%
15,565
-67
-0.4% -$1.39K
MRNA icon
1043
Moderna
MRNA
$21.6B
$319K ﹤0.01%
+2,992
New +$302K
TTWO icon
1044
Take-Two Interactive
TTWO
$46.1B
$318K ﹤0.01%
2,139
-101
-5% -$15.7K
WSFS icon
1045
WSFS Financial
WSFS
$4.14B
$315K ﹤0.01%
6,982
+30
+0.4% +$1.31K
KRE icon
1046
State Street SPDR S&P Regional Banking ETF
KRE
$4.51B
$314K ﹤0.01%
6,248
WTW icon
1047
Willis Towers Watson
WTW
$29.8B
$314K ﹤0.01%
1,140
+15
+1% +$3.95K
HRL icon
1048
Hormel Foods
HRL
$14.2B
$312K ﹤0.01%
8,955
+988
+12% +$31.5K
EGLE
1049
DELISTED
Eagle Bulk Shipping Inc.
EGLE
$312K ﹤0.01%
5,000
ZBRA icon
1050
Zebra Technologies
ZBRA
$13.5B
$311K ﹤0.01%
1,033
+158
+18% +$42.3K

Similar funds

Glenmede Trust's Q1 2024 Portfolio in Review

As of Q1 2024, Glenmede Trust held 1,397 positions worth $19.9B, up 3.5% from $19.3B the previous quarter. Its ten largest holdings account for 23% of the portfolio.

Glenmede Trust withdrew a net $801M in Q1 2024, closing 56 positions and reducing 573 holdings. Its most notable exit was Under Armour, an estimated $13.4M position sold in full.

By sector, the portfolio is most concentrated in Technology at 22% of assets, down from 23% a quarter earlier, followed by Healthcare and Financials.

Against the trend, Glenmede Trust opened a new position in Dynatrace worth $47.1M.

  • Glenmede Trust's largest Q1 2024 buy was Dynatrace: 1,013,219 shares worth $47.1M.
  • Glenmede Trust added most to Qualcomm in Q1 2024, an estimated $38.4M increase.
  • Glenmede Trust's biggest Q1 2024 reduction was KLA, cutting an estimated $78.4M.
  • Glenmede Trust fully exited Under Armour in Q1 2024, selling an estimated $13.4M.
  • Glenmede Trust's ten largest holdings make up 23% of its $19.9B portfolio in Q1 2024.
  • Glenmede Trust opened 101 new positions and closed 56 in Q1 2024.
  • Glenmede Trust's portfolio value rose 3.5% quarter-over-quarter to $19.9B.

Based on Glenmede Trust's 13F filing for Q1 2024, filed 15 May 2024.